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Five hundred years of 
glomerulonephritis
Genealogical studies are one way 
to establish the role of genes in the 
etiology of any disease. Scolari et al. 
have approached this age-old problem 
with remarkable perseverance and 
originality. Th ey studied the prevalence 
of primary glomerulonephritis in an 
isolated population from the Valtrompia 
valley in northern Italy. Th ey identifi ed 
42 patients with diff erent types of 
glomerular diseases, half of whom had 
renal biopsies. Scolari et al. constructed 
genealogies of the aff ected individuals by 
studying church records of births, deaths, 
and marriages in three villages dating 
back to 1570. It turned out that many of 
the pedigrees previously thought to be 
independent were related. With the use 
of molecular markers, this relationship 
was statistically demonstrated. All 
individuals could be traced back to 
common ancestors and fell into three 
large pedigrees. Th is study suggests 
that these patients share a common 
genetic susceptibility to develop primary 
glomerulonephritis. But the fact that 
the related individuals showed diff erent 
types of glomerulonephritis raises the 
question of whether they had inherited 
a component of a pathway that allowed 
glomerular injury of diverse causes. See 
page 1033. 
Payment for kidneys
It is a truism that the waiting list for 
kidney transplantation around the world 
is growing longer, and that the fi eld is 
at a loss to signifi cantly improve this 
situation. Expansion of the donor pool 
to include spouses and even friends has 
helped lessen the burden a little, but it 
is certainly not suffi  cient to overcome 
the growing demand. Increasingly, 
kidneys from donors that even a few 
years ago would have been considered 
too marginal are now being used with 
reasonable success. Meanwhile, in 
some regions of the world, kidneys 
period of aldosterone and salt loading. 
Aldosterone-infused wild-type mice 
had more proteinuria than those with 
deleted PAI-1, and the glomeruli 
were larger with greater mesangial 
expansion. Expression of several 
extracellular matrix proteins was also 
enhanced by aldosterone in both wild-
type and mutant mice, as was cardiac 
hypertrophy. However, there were some 
small diff erences in the expression of 
collagen subtypes between the wild-
type and knockout mice. Hence, it 
appears that PAI-1 was involved in the 
mechanism of action of aldosterone 
on glomerular structure and function. 
Th is action was probably due to greater 
systolic hypertension in the wild-type 
animals, but it raises the question of how 
PAI-1 protects the animals from elevated 
blood pressure. See page 1064. 
Acute renal failure 
during liver 
transplantation
Liver transplantation is a long and oft en 
traumatic procedure that can result 
in acute renal failure. When it does, it 
carries a poor prognosis. Cabezuelo et 
al. studied the rate of acute renal failure 
in a large number of consecutive liver 
transplants. Th ey found that almost 
one-third of the patients developed 
acute renal failure in the early phase of 
transplantation, and almost one-fi ft h 
had late appearance of the syndrome. 
As expected, most of the patients had 
ischemic acute tubular necrosis. Early 
acute renal failure was more likely to 
occur in patients who had had the 
condition before the transplantation, 
in patients whose albumin was 
below 3.2 g/dl, and in those with 
a long history of treatment with 
dopamine, which presumably refl ected 
cardiovascular instability. Patients who 
developed acute renal failure in the late 
phase of transplantation developed it, 
for the most part, in association with 
graft  failure or a bacterial infection. See 
page 1073.
are being sold, leading to ethical and 
humanitarian problems attendant on 
the commodifi cation of what is, ideally, 
a ‘gift  of life.’ As a solution, should one 
regulate the sale of kidneys? Or provide 
a benefi t to the families of potential 
donors to encourage donation, or to 
cover the expenses of transplantation? 
Transplantation experts E. and A. 
Friedman make an impassioned 
argument supporting these views. We 
asked two transplant surgeons and a 
nephrologist to discuss their views on 
the topic. Frank Delmonico thinks 
that ethical concerns prevent us from 
paying money to encourage donations, 
whereas Tony Monaco supports the 
idea of payment for kidney donations 
but argues that it should be regulated 
by the government. Donald Landry 
proposes alternatives to monetary 
encouragement, including the argument 
that organ donation can be driven by 
our inherent altruistic sense. Have you 
looked at your driver’s license lately? 
Did you check the box that indicates 
you are willing to donate your organs if 
you are in a fatal car accident? Th e issues 
surrounding kidney donation need to 
be debated and resolved with informed 
judgment by society as a whole. See 
pages  954, 955, 957 and  960. 
Aldosterone and 
plasminogen activator 
inhibitor
Aft er it was found that aldosterone 
antagonists had a signifi cantly protective 
eff ect on the outcome of congestive 
heart failure, the search began for a 
mechanism to link the known eff ects of 
aldosterone to its supposedly injurious 
eff ect. In a study reported in this 
issue, Ma et al. gave mice a high-salt 
diet with or without aldosterone and 
compared the results with those of the 
same treatments performed in mice 
defi cient in plasminogen activator 
inhibitor-1 (PAI-1). Th ey found that 
blood pressure was higher in wild-type 
than in knockout mice aft er a long 
